0001140361-12-019614.txt : 20120405 0001140361-12-019614.hdr.sgml : 20120405 20120405171931 ACCESSION NUMBER: 0001140361-12-019614 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120403 FILED AS OF DATE: 20120405 DATE AS OF CHANGE: 20120405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIRK THOMAS F CENTRAL INDEX KEY: 0001258258 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 12746491 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0305 4 2012-04-03 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001258258 KIRK THOMAS F 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 1 1 0 0 CEO Common Stock 2012-04-03 4 S 0 10990 21.8168 D 581097 D Common Stock 2012-04-04 4 S 0 114 21.8004 D 580983 D Option to Buy 13.50 2004-01-02 2013-01-02 Common Stock 100000 100000 D Option to Buy 15.67 2005-01-02 2014-01-02 Common Stock 100000 100000 D Option to Buy 8.08 2006-01-03 2015-01-03 Common Stock 100000 100000 D The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. These shares were sold at a range of sale prices from $21.70 to $21.93. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares totaling 20,000 shares from an initial grant of 20,000 shares of restricted stock made on March 7, 2012, (ii) unvested restricted shares and fully vested shares totaling 63,976 shares from an initial grant of 70,769 shares of restricted stock and performance shares made on March 25, 2011, (iii) unvested restricted shares and fully vested shares totaling 92,596 shares from an initial grant of 115,000 shares of restricted stock and performance shares made on March 30, 2010, (iv) unvested restricted shares and fully vested shares totaling 76,234 shares from an initial grant of 107,730 shares of restricted stock and performance shares made on November 13, 2008, (v) fully vested shares totaling 75,036 shares from an initial grant of 120,000 shares of restricted stock and performance shares made on August 9, 2007, and (vi) fully vested shares totaling 98,175 shares from an initial grant of 110,000 shares of restricted stock made on June 12, 2006. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This option vested over a four-year period from the date of grant and is now fully vested. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas F. Kirk 2012-04-05